Provided by Tiger Trade Technology Pte. Ltd.

Biogen

189.18
+5.242.85%
Post-market: 189.180.00000.00%19:56 EDT
Volume:775.20K
Turnover:145.77M
Market Cap:27.75B
PE:21.52
High:189.38
Open:184.91
Low:184.91
Close:183.94
52wk High:202.41
52wk Low:110.04
Shares:146.70M
Float Shares:146.23M
Volume Ratio:0.71
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.79
EPS(LYR):8.79
ROE:7.39%
ROA:6.14%
PB:1.52
PE(LYR):21.52

Loading ...

Biogen CEO Says Leqembi Preclinical Alzheimer's Study Fully Recruited, Results Expected in 2028

THOMSON REUTERS
·
Feb 06

Biogen Exec Says Co Will Approach New Launches in Europe From an Mfn Point of View, to Probably Target About Three or Four Countries to Start With

THOMSON REUTERS
·
Feb 06

Biogen Exec Says Lupus Drug Litifilimab Could Launch in 2028 IF Late‑Stage Data Are Positive

THOMSON REUTERS
·
Feb 06

Biogen's Cost-Cutting and Alzheimer's Drug Bet Drive Stronger-Than-Expected Profit Outlook

Stock News
·
Feb 06

Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio. -- Barrons.com

Dow Jones
·
Feb 06

BUZZ-Biogen rises after beating annual profit estimates

Reuters
·
Feb 06

BRIEF-Biogen Q4 Adjusted EPS USD 1.99 Vs. IBES Estimate USD 1.59

Reuters
·
Feb 06

Corrected-Biogen Outlook FY Adjusted EPS USD 15.25-16.25

THOMSON REUTERS
·
Feb 06

Biogen Outlook FY Adjusted EPS USD 15.28

THOMSON REUTERS
·
Feb 06

Biogen Q4 Non-GAAP Earnings, Revenue Fall; 2026 Outlook Set -- Shares Up Pre-Bell

MT Newswires Live
·
Feb 06

GUIDANCE: (BIIB) Biogen Expects 2026 Adjusted EPS Range $15.25 to $16.25, vs. FactSet Est of $14.93

MT Newswires Live
·
Feb 06

Earnings Flash (BIIB) Biogen Posts Q4 Adjusted EPS $1.99, vs. FactSet Est of $1.63

MT Newswires Live
·
Feb 06

Biogen reports Q4 adjusted EPS $1.99, consensus $1.63

TIPRANKS
·
Feb 06

Biogen Q4 2025 Adj. EPS $1.99 Beats $1.59 Estimate, Sales $2.279B Beat $2.204B Estimate

Benzinga
·
Feb 06

BRIEF-Eisai Co Ltd - Revenue Of Leqembi (Preliminary Basis)

Reuters
·
Feb 06

Biogen meldet für das Gesamtjahr 2025 Alzheimer-Kollaborationsumsatz von 177,7 Mio. USD mit einer Steigerung um 197 Prozent

Reuters
·
Feb 06

Biogen reports Q4 LEQEMBI global in-market sales of USD 134 million, up 54 percent year-over-year

Reuters
·
Feb 06

BRIEF-Biogen Sees 2026 Adj EPS $15.25 - $16.25 Versus IBES Estimate $14.92

Reuters
·
Feb 06

Biogen Q4 REV $2.28 Bln VS Ibes Estimate $2.20 Bln

THOMSON REUTERS
·
Feb 06

Biogen: Q4 Leqembi Global in-Market Sales of About $134 Mln

THOMSON REUTERS
·
Feb 06